HealthMerck, Moderna Melanoma Vaccine Study Succeeds

Merck and Moderna reported positive results from a large late-stage trial of their personalized mRNA cancer vaccine, saying it significantly reduced melanoma recurrence. Melanoma is the deadliest form of skin cancer.